Lemaitre Vascular (LMAT) EBIT Margin (2010 - 2026)

Lemaitre Vascular (LMAT) has reported EBIT Margin for 17 consecutive years, with 28.98% the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBIT Margin rose 385.0% year-over-year to 28.98% in Q2 2026; TTM through Jun 2026 was 29.46%, a 612.0% increase from a year earlier, with the FY2025 full-year figure at 27.21%, up 344.0% from the prior year.
• EBIT Margin was 28.98% for Q2 2026 at Lemaitre Vascular, up from 26.71% in the prior quarter.
• Over five years, EBIT Margin peaked at 33.27% in Q3 2025 and troughed at 13.74% in Q2 2022.
• A 5-year average of 22.32% and a median of 21.65% in 2024 frame the typical range for EBIT Margin.
• Across the five-year window, EBIT Margin plunged 1357 bps in 2022 and jumped 929 bps in 2025, its largest moves.
• Over 5 years, EBIT Margin stood at 17.01% in 2022, then increased by 23 bps to 20.88% in 2023, then grew by 10 bps to 23.07% in 2024, then rose by 27 bps to 29.22% in 2025, then fell by 1 bps to 28.98% in 2026.
• The last three EBIT Margin figures came in at 28.98% (Q2 2026), 26.71% (Q1 2026), and 29.22% (Q4 2025), per Business Quant data.